Dealroom's records hold 4,177 companies that reached a $1B valuation or a $1B exit. 282 of their founders started two or more of them, and 41 started three or more. Noubar Afeyan has started nine and Elon Musk seven.
Source: Dealroom.co
241 of the 282 started exactly two.
Source: Dealroom.co
Biotech is 28% of the unicorns started by serial founders and 14% of all unicorns. Flagship Pioneering and Third Rock Ventures create drug companies in-house, and their partners are listed as co-founders of each one.
Source: Dealroom.co
A decacorn here is a company worth $10B or more today: its market value if listed, its last funding round if private, or the price paid if it was bought. 13 founders started two or more.
Source: Dealroom.co
Starting a second unicorn is rare: about one founder of a unicorn in forty has done it. Biotech has twice its share among them, partly because venture studios such as Flagship Pioneering list their partners as co-founders of each company they start. 13 founders have started two or more companies worth $10B or more today.
Read more: Martin Varsavsky's companies and exits, from Viatel to Gameto.